ETP

  • Polaris Bio closes RMB70m Series B round led by Delian Capital

    Polaris Bio recently announced that it has completed 70 million yuan in a Series B financing round. This round was led by Delian Capital, with participation from Volcanics Venture, Baidu Ventures, ETP, Wuxi Financial, Ascendin Fund, and Morningside Venture Capital.

  • Sophonix closes RMB100m Series B round

    Sophonix has recently closed a 100 million US dollars Series B round of financing led by Zero2IPO Group, with participation from Delian Capital, Anlong Investment Management, Guotai Venture Capital, existing investor ETP. Yijun Capital served as the financial advisor for this round.
    This is one of the largest single financing to date in the field of POCT chemiluminescence in China.